Correlation Between Scandinavian Tobacco and Aquestive Therapeutics

Can any of the company-specific risk be diversified away by investing in both Scandinavian Tobacco and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scandinavian Tobacco and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scandinavian Tobacco Group and Aquestive Therapeutics, you can compare the effects of market volatilities on Scandinavian Tobacco and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scandinavian Tobacco with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scandinavian Tobacco and Aquestive Therapeutics.

Diversification Opportunities for Scandinavian Tobacco and Aquestive Therapeutics

0.72

Correlation Coefficient

Scandinavian Tobacco  Aquestive Therapeutics

Poor diversification

The 3 months correlation between Scandinavian and Aquestive is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Scandinavian Tobacco Group and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Scandinavian Tobacco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scandinavian Tobacco Group are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Scandinavian Tobacco i.e., Scandinavian Tobacco and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between Scandinavian Tobacco and Aquestive Therapeutics

Assuming the 90 days horizon Scandinavian Tobacco is expected to generate 10.63 times less return on investment than Aquestive Therapeutics. But when comparing it to its historical volatility, Scandinavian Tobacco Group is 3.06 times less risky than Aquestive Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  99.00  in Aquestive Therapeutics on October 3, 2024 and sell it today you would earn a total of  257.00  from holding Aquestive Therapeutics or generate 259.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.6%
Values	Daily Returns

Scandinavian Tobacco Group  vs.  Aquestive Therapeutics

Scandinavian Tobacco

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scandinavian Tobacco Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Aquestive Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Scandinavian Tobacco and Aquestive Therapeutics

The main advantage of trading using opposite Scandinavian Tobacco and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scandinavian Tobacco position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.

The idea behind Scandinavian Tobacco Group and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.